Editorial overview: COVID-19 therapy: From lung disease to systemic disorder

Curr Opin Pharmacol. 2022 Aug:65:102246. doi: 10.1016/j.coph.2022.102246. Epub 2022 May 8.

Authors

Nora A Fierro¹, Jesus Torres-Flores², Santiago Mirazo³

Affiliations

¹ Department of Immunology, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Mexico City, Mexico. Electronic address: noraalma@iibiomedicas.unam.mx.
² Consejo Nacional de Ciencia y Tecnología, Mexico City, Mexico.
³ Laboratory of Virology, Universidad de la República, Montevideo, Uruguay.

No abstract available

Publication types

Editorial

MeSH terms

COVID-19 Drug Treatment*
Humans
Lung
SARS-CoV-2